1.45
price up icon0.03%   0.00
 
loading

Immuneering Corp Azioni (IMRX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
5.99%
15.33
16.30 13.93 13.50 14.68
Operating Income/Loss
5.99%
-15.33
-16.30 -13.93 -13.50 -14.68
Income/Loss From Continuing Operations Before Tax
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Income/Loss From Continuing Operations After Tax
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Net Income/Loss
5.14%
-14.31
-15.08 -12.60 -12.19 -13.60
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,114%
29.37
0.2876 29.27 28.65 26.44
Diluted Average Shares
10,114%
29.37
0.2876 29.27 28.65 26.44
Basic Earnings Per Share
5.77%
-0.49
-0.52 -0.43 -0.43 -0.51
Diluted Earnings Per Share
5.77%
-0.49
-0.52 -0.43 -0.43 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.65
price up icon 0.63%
$70.47
price up icon 1.28%
$32.49
price up icon 0.64%
$23.90
price up icon 1.85%
$108.35
price up icon 3.89%
biotechnology ONC
$247.87
price up icon 1.21%
Capitalizzazione:     |  Volume (24 ore):